This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

26 Oct 2012

Sanofi to continue developing Prednisporin under sub-licencing agreement

Sanofi will continue development of Prednisporin, but expects to sub-licence the work to a third-party.


Sanofi has announced in its latest quarterly financial update that the company intends to continue developing Prednisporin under the terms of a sublicense agreement with a third party.

Related News